Insider Buying: Palvella Therapeutics (NASDAQ:PVLA) Director Buys 4,000 Shares of Stock

Palvella Therapeutics (NASDAQ:PVLA - Get Free Report) Director George M. Jenkins purchased 4,000 shares of Palvella Therapeutics stock in a transaction dated Wednesday, December 18th. The stock was bought at an average cost of $12.93 per share, with a total value of $51,720.00. Following the completion of the transaction, the director now owns 180,671 shares in the company, valued at approximately $2,336,076.03. This represents a 2.26 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.

Palvella Therapeutics Stock Performance

Shares of PVLA opened at $12.00 on Friday. Palvella Therapeutics has a 12 month low of $6.20 and a 12 month high of $22.32.

Analysts Set New Price Targets

Separately, Cantor Fitzgerald initiated coverage on shares of Palvella Therapeutics in a research report on Wednesday. They issued an "overweight" rating on the stock.

Read Our Latest Research Report on PVLA

Featured Articles

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Palvella Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Palvella Therapeutics and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles